Schering-Plough Licenses Intranasal Pleconaril For Common Cold
The product formulation from ViroPharma is in Phase II. The oral form of the drug, Sanofi's Picovir, received a "not approvable" letter in 2002 from FDA.
The product formulation from ViroPharma is in Phase II. The oral form of the drug, Sanofi's Picovir, received a "not approvable" letter in 2002 from FDA.